Medical treatment for primary sclerosing cholangitis: Risk versus benefit

Paul Angulo; Keith D. Lindor

doi:10.1002/hep.510320429

Medical treatment for primary sclerosing cholangitis: Risk versus benefit

Paul Angulo, Keith D. Lindor

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	871-872
Number of pages	2
Journal	Hepatology
Volume	32
Issue number	4 I
DOIs	https://doi.org/10.1002/hep.510320429
State	Published - 2000
Externally published	Yes

ASJC Scopus subject areas

Hepatology

Access to Document

10.1002/hep.510320429

Cite this

@article{df2d68fc562b403abdf4119dc6c1b5ee,

title = "Medical treatment for primary sclerosing cholangitis: Risk versus benefit",

author = "Paul Angulo and Lindor, {Keith D.}",

year = "2000",

doi = "10.1002/hep.510320429",

language = "English (US)",

volume = "32",

pages = "871--872",

journal = "Hepatology",

issn = "0270-9139",

publisher = "John Wiley and Sons Ltd",

number = "4 I",

}

TY - JOUR

T1 - Medical treatment for primary sclerosing cholangitis

T2 - Risk versus benefit

AU - Angulo, Paul

AU - Lindor, Keith D.

PY - 2000

Y1 - 2000

UR - http://www.scopus.com/inward/record.url?scp=0033802365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033802365&partnerID=8YFLogxK

U2 - 10.1002/hep.510320429

DO - 10.1002/hep.510320429

M3 - Comment/debate

C2 - 11003638

AN - SCOPUS:0033802365

SN - 0270-9139

VL - 32

SP - 871

EP - 872

JO - Hepatology

JF - Hepatology

IS - 4 I

ER -

Medical treatment for primary sclerosing cholangitis: Risk versus benefit

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this